Ladone Mary Kay
SEC CIK 1760737 · EDGAR
BoughtSold
Most active insiders at KMTS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Webster Brian Daniel | See Remarks, Dir | — | $5.07M |
| 2 | Mahboob Vaseem | CFO | — | $1.27M |
| 3 | Umberger Traci S | See Remarks, Dir | — | $879.1K |
| 4 | Ford Alfred J Jr | Chief Commercial Off | — | $793.7K |
| 5 | Moran Timothy P. | Chief Business Off | — | $348.3K |
| 6 | COHEN RAYMOND W | Dir | $199.8K | — |
| 7 | Hanley Conor | Dir | — | $143.8K |
| 8 | Ladone Mary Kay | Dir | — | $98.5K |
| 9 | Schwartz Jeffrey Lawrence | Dir, 10% | — | $97.9K |
| 10 | Kwo Elizabeth | Dir | — | $97.3K |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 20:25 | 2026-09-08 | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | Ladone Mary Kay | Dir | S - Sale | $25.20 | -3,908 | 37.5K | -9% | -$98.5K | |
| 2026-09-10 20:25 | 2026-09-09 | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | Ladone Mary Kay | Dir | A - Grant | — | +7,217 | 44.7K | +19% | — | |
| 2026-06-09 16:19 | 2026-06-05 | INGN | Inogen Inc | Ladone Mary Kay | Dir | A - Grant | $0.00 | +28.1K | 105.0K | +37% | $0 | |
| D | 2026-06-04 16:46 | 2026-06-02 | BVS | Bioventus Inc. | Ladone Mary Kay | Dir | M - OptEx | $0.00 | +32.3K | 111.3K | +41% | $0 |
| D | 2026-01-06 | 2026-01-02 | NOVT | NOVANTA INC | Ladone Mary Kay | Dir | M - OptEx | — | +1,325 | 1,897 | +232% | — |
| 2025-09-08 | 2025-09-04 | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | Ladone Mary Kay | Dir | A - Grant | — | +10.9K | 23.9K | +84% | — | |
| D | 2025-07-14 | 2025-07-11 | NOVT | NOVANTA INC | Ladone Mary Kay | Dir | M - OptEx | — | +572 | 572 | New | — |
| D | 2025-06-04 | 2025-06-02 | BVS | Bioventus Inc. | Ladone Mary Kay | Dir | M - OptEx | $0.00 | +26.5K | 79.0K | +50% | $0 |
| 2025-05-16 | 2025-05-14 | INGN | Inogen Inc | Ladone Mary Kay | Dir | A - Grant | $0.00 | +30.6K | 76.9K | +66% | $0 | |
| D | 2024-06-18 | 2024-06-16 | BVS | Bioventus Inc. | Ladone Mary Kay | Dir | M - OptEx | $0.00 | +1,814 | 52.5K | +4% | $0 |
| D | 2024-06-11 | 2024-06-07 | BVS | Bioventus Inc. | Ladone Mary Kay | Dir | M - OptEx | $0.00 | +30.4K | 50.7K | +150% | $0 |
| 2024-06-07 | 2024-06-05 | INGN | Inogen Inc | Ladone Mary Kay | Dir | A - Grant | $0.00 | +21.9K | 46.3K | +90% | $0 | |
| D | 2023-06-20 | 2023-06-16 | BVS | Bioventus Inc. | Ladone Mary Kay | Dir | M - OptEx | $0.00 | +1,813 | 20.3K | +10% | $0 |
| D | 2023-06-08 | 2023-06-06 | BVS | Bioventus Inc. | Ladone Mary Kay | Dir | M - OptEx | $0.00 | +16.6K | 18.5K | +918% | $0 |
| 2023-06-02 | 2023-05-31 | INGN | Inogen Inc | Ladone Mary Kay | Dir | A - Grant | $0.00 | +17.1K | 24.4K | +234% | $0 | |
| D | 2022-06-22 | 2022-06-16 | BVS | Bioventus Inc. | Ladone Mary Kay | Dir | M - OptEx | $0.00 | +1,813 | 1,813 | New | $0 |
| 2022-06-10 | 2022-06-08 | INGN | Inogen Inc | Ladone Mary Kay | Dir | A - Grant | $0.00 | +6,849 | 7,308 | +1,492% | $0 | |
| 2022-03-24 | 2022-03-22 | INGN | Inogen Inc | Ladone Mary Kay | Dir | A - Grant | $0.00 | +459 | 459 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations